![VBI Vaccines Inc. logo](/logos/VBIV.webp)
VBI Vaccines Inc.
NASDAQ:VBIV
Overview | Financials
Company Name | VBI Vaccines Inc. |
Symbol | VBIV |
Currency | USD |
Price | 0.065 |
Market Cap | 1,872,954 |
Dividend Yield | 0% |
52-week-range | 0.013 - 1.35 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jeffery R. Baxter FCMA |
Website | https://www.vbivaccines.com |
An error occurred while fetching data.
About VBI Vaccines Inc.
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD